nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2C9—brain cancer	0.56	1	CbGaD
Paroxetine—CYP2D6—Lomustine—brain cancer	0.0399	0.418	CbGbCtD
Paroxetine—CYP2D6—Hydroxyurea—brain cancer	0.0302	0.317	CbGbCtD
Paroxetine—CYP2C8—Etoposide—brain cancer	0.0151	0.158	CbGbCtD
Paroxetine—TACR1—trigeminal nerve—brain cancer	0.0106	0.111	CbGeAlD
Paroxetine—ABCB1—Etoposide—brain cancer	0.0102	0.107	CbGbCtD
Paroxetine—TACR1—cranial nerve—brain cancer	0.00754	0.0789	CbGeAlD
Paroxetine—HTR2A—choroid plexus—brain cancer	0.00511	0.0534	CbGeAlD
Paroxetine—TACR1—ganglion—brain cancer	0.00382	0.0399	CbGeAlD
Paroxetine—SLC6A3—telencephalic ventricle—brain cancer	0.00308	0.0323	CbGeAlD
Paroxetine—HTR2A—trigeminal nerve—brain cancer	0.00258	0.027	CbGeAlD
Paroxetine—HTR2A—cerebellar cortex—brain cancer	0.00257	0.0269	CbGeAlD
Paroxetine—HTR2A—vein—brain cancer	0.00233	0.0244	CbGeAlD
Paroxetine—SLC6A3—ganglion—brain cancer	0.00192	0.0201	CbGeAlD
Paroxetine—HTR2A—cranial nerve—brain cancer	0.00184	0.0192	CbGeAlD
Paroxetine—HTR2A—pons—brain cancer	0.00182	0.019	CbGeAlD
Paroxetine—SLC6A4—ganglion—brain cancer	0.00176	0.0184	CbGeAlD
Paroxetine—TACR1—brainstem—brain cancer	0.00166	0.0174	CbGeAlD
Paroxetine—SLC6A2—ganglion—brain cancer	0.00155	0.0162	CbGeAlD
Paroxetine—HTR2A—telencephalic ventricle—brain cancer	0.0015	0.0157	CbGeAlD
Paroxetine—TACR1—telencephalon—brain cancer	0.00147	0.0154	CbGeAlD
Paroxetine—SLC6A3—hindbrain—brain cancer	0.00146	0.0152	CbGeAlD
Paroxetine—SLC6A4—hindbrain—brain cancer	0.00133	0.014	CbGeAlD
Paroxetine—HTR2A—pineal body—brain cancer	0.0013	0.0136	CbGeAlD
Paroxetine—TACR1—spinal cord—brain cancer	0.00103	0.0108	CbGeAlD
Paroxetine—HTR2A—ganglion—brain cancer	0.000931	0.00974	CbGeAlD
Paroxetine—TACR1—endocrine gland—brain cancer	0.000929	0.00972	CbGeAlD
Paroxetine—TACR1—head—brain cancer	0.000917	0.0096	CbGeAlD
Paroxetine—CHRM4—head—brain cancer	0.000862	0.00902	CbGeAlD
Paroxetine—TACR1—central nervous system—brain cancer	0.000837	0.00876	CbGeAlD
Paroxetine—SLC6A3—brainstem—brain cancer	0.000835	0.00873	CbGeAlD
Paroxetine—HTR2A—endothelium—brain cancer	0.000803	0.0084	CbGeAlD
Paroxetine—CHRM4—central nervous system—brain cancer	0.000787	0.00824	CbGeAlD
Paroxetine—SLC6A4—brainstem—brain cancer	0.000765	0.008	CbGeAlD
Paroxetine—CHRM2—telencephalon—brain cancer	0.000743	0.00777	CbGeAlD
Paroxetine—SLC6A3—telencephalon—brain cancer	0.000741	0.00775	CbGeAlD
Paroxetine—HTR2A—blood vessel—brain cancer	0.00074	0.00775	CbGeAlD
Paroxetine—HTR2A—hindbrain—brain cancer	0.000706	0.00739	CbGeAlD
Paroxetine—SLC6A4—telencephalon—brain cancer	0.000679	0.0071	CbGeAlD
Paroxetine—CHRM1—telencephalon—brain cancer	0.000676	0.00708	CbGeAlD
Paroxetine—CHRM5—head—brain cancer	0.000674	0.00705	CbGeAlD
Paroxetine—SLC6A2—brainstem—brain cancer	0.000673	0.00705	CbGeAlD
Paroxetine—TACR1—brain—brain cancer	0.000664	0.00695	CbGeAlD
Paroxetine—CYP2D6—hindbrain—brain cancer	0.000643	0.00673	CbGeAlD
Paroxetine—CHRM4—brain—brain cancer	0.000625	0.00654	CbGeAlD
Paroxetine—CHRM5—central nervous system—brain cancer	0.000615	0.00644	CbGeAlD
Paroxetine—CHRM3—telencephalon—brain cancer	0.000605	0.00633	CbGeAlD
Paroxetine—SLC6A2—telencephalon—brain cancer	0.000598	0.00625	CbGeAlD
Paroxetine—SLC6A3—midbrain—brain cancer	0.000532	0.00557	CbGeAlD
Paroxetine—SLC6A3—spinal cord—brain cancer	0.000519	0.00543	CbGeAlD
Paroxetine—SLC6A2—gonad—brain cancer	0.000499	0.00522	CbGeAlD
Paroxetine—CHRM5—brain—brain cancer	0.000488	0.00511	CbGeAlD
Paroxetine—SLC6A4—midbrain—brain cancer	0.000487	0.0051	CbGeAlD
Paroxetine—ABCB1—blood vessel—brain cancer	0.000485	0.00508	CbGeAlD
Paroxetine—SLC6A4—spinal cord—brain cancer	0.000476	0.00498	CbGeAlD
Paroxetine—SLC6A2—medulla oblongata—brain cancer	0.000469	0.00491	CbGeAlD
Paroxetine—CHRM2—endocrine gland—brain cancer	0.000469	0.0049	CbGeAlD
Paroxetine—CHRM2—head—brain cancer	0.000463	0.00484	CbGeAlD
Paroxetine—SLC6A3—head—brain cancer	0.000461	0.00483	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—brain cancer	0.000428	0.00448	CbGeAlD
Paroxetine—CHRM1—endocrine gland—brain cancer	0.000426	0.00446	CbGeAlD
Paroxetine—SLC6A4—head—brain cancer	0.000423	0.00442	CbGeAlD
Paroxetine—CHRM2—central nervous system—brain cancer	0.000422	0.00442	CbGeAlD
Paroxetine—CHRM1—head—brain cancer	0.000421	0.00441	CbGeAlD
Paroxetine—SLC6A3—central nervous system—brain cancer	0.000421	0.00441	CbGeAlD
Paroxetine—SLC6A3—cerebellum—brain cancer	0.000411	0.00431	CbGeAlD
Paroxetine—HTR2A—brainstem—brain cancer	0.000405	0.00424	CbGeAlD
Paroxetine—CYP2C8—pituitary gland—brain cancer	0.0004	0.00418	CbGeAlD
Paroxetine—SLC6A4—central nervous system—brain cancer	0.000386	0.00404	CbGeAlD
Paroxetine—CHRM1—central nervous system—brain cancer	0.000384	0.00402	CbGeAlD
Paroxetine—CHRM3—endocrine gland—brain cancer	0.000382	0.00399	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—brain cancer	0.000377	0.00394	CbGeAlD
Paroxetine—CHRM3—head—brain cancer	0.000377	0.00394	CbGeAlD
Paroxetine—SLC6A2—head—brain cancer	0.000372	0.00389	CbGeAlD
Paroxetine—CYP2D6—brainstem—brain cancer	0.000369	0.00386	CbGeAlD
Paroxetine—CYP2B6—gonad—brain cancer	0.000367	0.00385	CbGeAlD
Paroxetine—HTR2A—telencephalon—brain cancer	0.000359	0.00376	CbGeAlD
Paroxetine—CHRM3—central nervous system—brain cancer	0.000344	0.0036	CbGeAlD
Paroxetine—SLC6A2—central nervous system—brain cancer	0.00034	0.00355	CbGeAlD
Paroxetine—CHRM2—brain—brain cancer	0.000335	0.00351	CbGeAlD
Paroxetine—SLC6A3—brain—brain cancer	0.000334	0.0035	CbGeAlD
Paroxetine—CYP2D6—telencephalon—brain cancer	0.000327	0.00342	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—brain cancer	0.00031	0.00324	CbGeAlD
Paroxetine—SLC6A4—brain—brain cancer	0.000306	0.00321	CbGeAlD
Paroxetine—CHRM1—brain—brain cancer	0.000305	0.00319	CbGeAlD
Paroxetine—HTR2A—gonad—brain cancer	0.0003	0.00314	CbGeAlD
Paroxetine—HTR2A—pituitary gland—brain cancer	0.000292	0.00306	CbGeAlD
Paroxetine—HTR2A—medulla oblongata—brain cancer	0.000282	0.00295	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—brain cancer	0.000278	0.00291	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—brain cancer	0.000275	0.00288	CbGeAlD
Paroxetine—CYP2B6—head—brain cancer	0.000274	0.00287	CbGeAlD
Paroxetine—CHRM3—brain—brain cancer	0.000273	0.00286	CbGeAlD
Paroxetine—SLC6A2—brain—brain cancer	0.00027	0.00282	CbGeAlD
Paroxetine—HTR2A—midbrain—brain cancer	0.000258	0.0027	CbGeAlD
Paroxetine—HTR2A—spinal cord—brain cancer	0.000252	0.00263	CbGeAlD
Paroxetine—CYP2B6—central nervous system—brain cancer	0.00025	0.00262	CbGeAlD
Paroxetine—ABCB1—telencephalon—brain cancer	0.000235	0.00246	CbGeAlD
Paroxetine—HTR2A—endocrine gland—brain cancer	0.000227	0.00237	CbGeAlD
Paroxetine—HTR2A—head—brain cancer	0.000224	0.00234	CbGeAlD
Paroxetine—CYP2C8—brain—brain cancer	0.000221	0.00232	CbGeAlD
Paroxetine—CYP2D6—endocrine gland—brain cancer	0.000206	0.00216	CbGeAlD
Paroxetine—Cramp muscle—Etoposide—brain cancer	0.000206	0.00103	CcSEcCtD
Paroxetine—Haemoglobin—Carmustine—brain cancer	0.000205	0.00103	CcSEcCtD
Paroxetine—Haemorrhage—Carmustine—brain cancer	0.000204	0.00102	CcSEcCtD
Paroxetine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000204	0.00102	CcSEcCtD
Paroxetine—HTR2A—central nervous system—brain cancer	0.000204	0.00214	CbGeAlD
Paroxetine—CYP2D6—head—brain cancer	0.000204	0.00213	CbGeAlD
Paroxetine—Anaemia—Hydroxyurea—brain cancer	0.000203	0.00102	CcSEcCtD
Paroxetine—Hallucination—Carmustine—brain cancer	0.000203	0.00102	CcSEcCtD
Paroxetine—Hypoaesthesia—Carmustine—brain cancer	0.000203	0.00102	CcSEcCtD
Paroxetine—Decreased appetite—Procarbazine—brain cancer	0.000202	0.00101	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000202	0.00101	CcSEcCtD
Paroxetine—Oedema peripheral—Carmustine—brain cancer	0.000201	0.00101	CcSEcCtD
Paroxetine—Connective tissue disorder—Carmustine—brain cancer	0.000201	0.00101	CcSEcCtD
Paroxetine—Fatigue—Procarbazine—brain cancer	0.0002	0.001	CcSEcCtD
Paroxetine—HTR2A—cerebellum—brain cancer	0.0002	0.00209	CbGeAlD
Paroxetine—CYP2B6—brain—brain cancer	0.000199	0.00208	CbGeAlD
Paroxetine—Haemoglobin—Temozolomide—brain cancer	0.000199	0.000995	CcSEcCtD
Paroxetine—Malaise—Hydroxyurea—brain cancer	0.000198	0.000994	CcSEcCtD
Paroxetine—Constipation—Procarbazine—brain cancer	0.000198	0.000994	CcSEcCtD
Paroxetine—Pain—Procarbazine—brain cancer	0.000198	0.000994	CcSEcCtD
Paroxetine—Haemorrhage—Temozolomide—brain cancer	0.000198	0.00099	CcSEcCtD
Paroxetine—Hepatitis—Temozolomide—brain cancer	0.000198	0.00099	CcSEcCtD
Paroxetine—Dysphagia—Etoposide—brain cancer	0.000197	0.000989	CcSEcCtD
Paroxetine—Leukopenia—Hydroxyurea—brain cancer	0.000197	0.000987	CcSEcCtD
Paroxetine—Visual impairment—Carmustine—brain cancer	0.000197	0.000987	CcSEcCtD
Paroxetine—Hallucination—Temozolomide—brain cancer	0.000197	0.000985	CcSEcCtD
Paroxetine—Hypoaesthesia—Temozolomide—brain cancer	0.000197	0.000985	CcSEcCtD
Paroxetine—ABCB1—gonad—brain cancer	0.000196	0.00206	CbGeAlD
Paroxetine—Pharyngitis—Temozolomide—brain cancer	0.000196	0.000982	CcSEcCtD
Paroxetine—Oedema peripheral—Temozolomide—brain cancer	0.000195	0.000975	CcSEcCtD
Paroxetine—Connective tissue disorder—Temozolomide—brain cancer	0.000194	0.000973	CcSEcCtD
Paroxetine—Sweating increased—Etoposide—brain cancer	0.000192	0.000964	CcSEcCtD
Paroxetine—ABCB1—pituitary gland—brain cancer	0.000192	0.00201	CbGeAlD
Paroxetine—Feeling abnormal—Procarbazine—brain cancer	0.000191	0.000958	CcSEcCtD
Paroxetine—Eye disorder—Carmustine—brain cancer	0.000191	0.000957	CcSEcCtD
Paroxetine—Convulsion—Hydroxyurea—brain cancer	0.000191	0.000955	CcSEcCtD
Paroxetine—Visual impairment—Temozolomide—brain cancer	0.00019	0.000954	CcSEcCtD
Paroxetine—Gastrointestinal pain—Procarbazine—brain cancer	0.00019	0.000951	CcSEcCtD
Paroxetine—Flushing—Carmustine—brain cancer	0.00019	0.00095	CcSEcCtD
Paroxetine—Pancytopenia—Etoposide—brain cancer	0.000188	0.00094	CcSEcCtD
Paroxetine—Erythema multiforme—Temozolomide—brain cancer	0.000187	0.000936	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000186	0.000932	CcSEcCtD
Paroxetine—CYP2D6—central nervous system—brain cancer	0.000186	0.00195	CbGeAlD
Paroxetine—Discomfort—Hydroxyurea—brain cancer	0.000185	0.000928	CcSEcCtD
Paroxetine—ABCB1—medulla oblongata—brain cancer	0.000185	0.00194	CbGeAlD
Paroxetine—Eye disorder—Temozolomide—brain cancer	0.000185	0.000925	CcSEcCtD
Paroxetine—Urticaria—Procarbazine—brain cancer	0.000184	0.000924	CcSEcCtD
Paroxetine—Tinnitus—Temozolomide—brain cancer	0.000184	0.000923	CcSEcCtD
Paroxetine—Body temperature increased—Procarbazine—brain cancer	0.000183	0.000919	CcSEcCtD
Paroxetine—Abdominal pain—Procarbazine—brain cancer	0.000183	0.000919	CcSEcCtD
Paroxetine—Flushing—Temozolomide—brain cancer	0.000183	0.000918	CcSEcCtD
Paroxetine—Cardiac disorder—Temozolomide—brain cancer	0.000183	0.000918	CcSEcCtD
Paroxetine—Arrhythmia—Carmustine—brain cancer	0.000183	0.000915	CcSEcCtD
Paroxetine—CYP2D6—cerebellum—brain cancer	0.000182	0.0019	CbGeAlD
Paroxetine—Alopecia—Carmustine—brain cancer	0.000181	0.000905	CcSEcCtD
Paroxetine—Oedema—Hydroxyurea—brain cancer	0.00018	0.0009	CcSEcCtD
Paroxetine—Angiopathy—Temozolomide—brain cancer	0.000179	0.000898	CcSEcCtD
Paroxetine—Mental disorder—Carmustine—brain cancer	0.000179	0.000897	CcSEcCtD
Paroxetine—Infection—Hydroxyurea—brain cancer	0.000178	0.000894	CcSEcCtD
Paroxetine—Immune system disorder—Temozolomide—brain cancer	0.000178	0.000894	CcSEcCtD
Paroxetine—Mediastinal disorder—Temozolomide—brain cancer	0.000178	0.000892	CcSEcCtD
Paroxetine—Malnutrition—Carmustine—brain cancer	0.000178	0.000891	CcSEcCtD
Paroxetine—Erythema—Carmustine—brain cancer	0.000178	0.000891	CcSEcCtD
Paroxetine—Chills—Temozolomide—brain cancer	0.000177	0.000888	CcSEcCtD
Paroxetine—Pneumonia—Etoposide—brain cancer	0.000177	0.000887	CcSEcCtD
Paroxetine—Nervous system disorder—Hydroxyurea—brain cancer	0.000176	0.000883	CcSEcCtD
Paroxetine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000176	0.000881	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000175	0.000875	CcSEcCtD
Paroxetine—Alopecia—Temozolomide—brain cancer	0.000175	0.000875	CcSEcCtD
Paroxetine—Skin disorder—Hydroxyurea—brain cancer	0.000174	0.000874	CcSEcCtD
Paroxetine—Acute coronary syndrome—Etoposide—brain cancer	0.000174	0.00087	CcSEcCtD
Paroxetine—Mental disorder—Temozolomide—brain cancer	0.000173	0.000867	CcSEcCtD
Paroxetine—Myocardial infarction—Etoposide—brain cancer	0.000173	0.000865	CcSEcCtD
Paroxetine—Neuropathy peripheral—Etoposide—brain cancer	0.000173	0.000865	CcSEcCtD
Paroxetine—Back pain—Carmustine—brain cancer	0.000172	0.000862	CcSEcCtD
Paroxetine—Erythema—Temozolomide—brain cancer	0.000172	0.000862	CcSEcCtD
Paroxetine—Malnutrition—Temozolomide—brain cancer	0.000172	0.000862	CcSEcCtD
Paroxetine—Stomatitis—Etoposide—brain cancer	0.000172	0.00086	CcSEcCtD
Paroxetine—Jaundice—Etoposide—brain cancer	0.000172	0.00086	CcSEcCtD
Paroxetine—Hypersensitivity—Procarbazine—brain cancer	0.000171	0.000857	CcSEcCtD
Paroxetine—ABCB1—midbrain—brain cancer	0.000169	0.00177	CbGeAlD
Paroxetine—Dysgeusia—Temozolomide—brain cancer	0.000168	0.000844	CcSEcCtD
Paroxetine—Vision blurred—Carmustine—brain cancer	0.000168	0.00084	CcSEcCtD
Paroxetine—Tremor—Carmustine—brain cancer	0.000167	0.000835	CcSEcCtD
Paroxetine—Asthenia—Procarbazine—brain cancer	0.000167	0.000834	CcSEcCtD
Paroxetine—Hepatobiliary disease—Etoposide—brain cancer	0.000167	0.000834	CcSEcCtD
Paroxetine—Back pain—Temozolomide—brain cancer	0.000166	0.000833	CcSEcCtD
Paroxetine—ABCB1—spinal cord—brain cancer	0.000165	0.00173	CbGeAlD
Paroxetine—Anaemia—Carmustine—brain cancer	0.000164	0.000824	CcSEcCtD
Paroxetine—Agranulocytosis—Etoposide—brain cancer	0.000164	0.000823	CcSEcCtD
Paroxetine—Pruritus—Procarbazine—brain cancer	0.000164	0.000823	CcSEcCtD
Paroxetine—Agitation—Carmustine—brain cancer	0.000164	0.000819	CcSEcCtD
Paroxetine—HTR2A—brain—brain cancer	0.000162	0.0017	CbGeAlD
Paroxetine—Vision blurred—Temozolomide—brain cancer	0.000162	0.000812	CcSEcCtD
Paroxetine—Tremor—Temozolomide—brain cancer	0.000161	0.000807	CcSEcCtD
Paroxetine—Dyspnoea—Hydroxyurea—brain cancer	0.00016	0.000802	CcSEcCtD
Paroxetine—Somnolence—Hydroxyurea—brain cancer	0.00016	0.0008	CcSEcCtD
Paroxetine—Ill-defined disorder—Temozolomide—brain cancer	0.00016	0.000799	CcSEcCtD
Paroxetine—Leukopenia—Carmustine—brain cancer	0.000159	0.000798	CcSEcCtD
Paroxetine—Anaemia—Temozolomide—brain cancer	0.000159	0.000796	CcSEcCtD
Paroxetine—Diarrhoea—Procarbazine—brain cancer	0.000159	0.000796	CcSEcCtD
Paroxetine—Dyspepsia—Hydroxyurea—brain cancer	0.000158	0.000792	CcSEcCtD
Paroxetine—Agitation—Temozolomide—brain cancer	0.000158	0.000792	CcSEcCtD
Paroxetine—Hypoaesthesia—Etoposide—brain cancer	0.000157	0.000788	CcSEcCtD
Paroxetine—Angioedema—Temozolomide—brain cancer	0.000157	0.000787	CcSEcCtD
Paroxetine—Decreased appetite—Hydroxyurea—brain cancer	0.000156	0.000782	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000155	0.000777	CcSEcCtD
Paroxetine—Malaise—Temozolomide—brain cancer	0.000155	0.000777	CcSEcCtD
Paroxetine—Fatigue—Hydroxyurea—brain cancer	0.000155	0.000776	CcSEcCtD
Paroxetine—Vertigo—Temozolomide—brain cancer	0.000154	0.000774	CcSEcCtD
Paroxetine—Convulsion—Carmustine—brain cancer	0.000154	0.000772	CcSEcCtD
Paroxetine—Leukopenia—Temozolomide—brain cancer	0.000154	0.000771	CcSEcCtD
Paroxetine—Hypertension—Carmustine—brain cancer	0.000154	0.00077	CcSEcCtD
Paroxetine—Pain—Hydroxyurea—brain cancer	0.000154	0.00077	CcSEcCtD
Paroxetine—Constipation—Hydroxyurea—brain cancer	0.000154	0.00077	CcSEcCtD
Paroxetine—Dizziness—Procarbazine—brain cancer	0.000153	0.000769	CcSEcCtD
Paroxetine—Palpitations—Temozolomide—brain cancer	0.000152	0.000761	CcSEcCtD
Paroxetine—Myalgia—Carmustine—brain cancer	0.000151	0.000759	CcSEcCtD
Paroxetine—Chest pain—Carmustine—brain cancer	0.000151	0.000759	CcSEcCtD
Paroxetine—Anxiety—Carmustine—brain cancer	0.000151	0.000756	CcSEcCtD
Paroxetine—Cough—Temozolomide—brain cancer	0.00015	0.000752	CcSEcCtD
Paroxetine—Erythema multiforme—Etoposide—brain cancer	0.000149	0.000749	CcSEcCtD
Paroxetine—Convulsion—Temozolomide—brain cancer	0.000149	0.000746	CcSEcCtD
Paroxetine—Hypertension—Temozolomide—brain cancer	0.000148	0.000744	CcSEcCtD
Paroxetine—ABCB1—endocrine gland—brain cancer	0.000148	0.00155	CbGeAlD
Paroxetine—Feeling abnormal—Hydroxyurea—brain cancer	0.000148	0.000742	CcSEcCtD
Paroxetine—Eye disorder—Etoposide—brain cancer	0.000148	0.00074	CcSEcCtD
Paroxetine—CYP2D6—brain—brain cancer	0.000148	0.00155	CbGeAlD
Paroxetine—Vomiting—Procarbazine—brain cancer	0.000148	0.000739	CcSEcCtD
Paroxetine—Flushing—Etoposide—brain cancer	0.000147	0.000735	CcSEcCtD
Paroxetine—Cardiac disorder—Etoposide—brain cancer	0.000147	0.000735	CcSEcCtD
Paroxetine—ABCB1—head—brain cancer	0.000147	0.00153	CbGeAlD
Paroxetine—Confusional state—Carmustine—brain cancer	0.000146	0.000734	CcSEcCtD
Paroxetine—Myalgia—Temozolomide—brain cancer	0.000146	0.000733	CcSEcCtD
Paroxetine—Arthralgia—Temozolomide—brain cancer	0.000146	0.000733	CcSEcCtD
Paroxetine—Rash—Procarbazine—brain cancer	0.000146	0.000733	CcSEcCtD
Paroxetine—Dermatitis—Procarbazine—brain cancer	0.000146	0.000733	CcSEcCtD
Paroxetine—Anxiety—Temozolomide—brain cancer	0.000146	0.000731	CcSEcCtD
Paroxetine—Headache—Procarbazine—brain cancer	0.000145	0.000729	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000145	0.000728	CcSEcCtD
Paroxetine—Oedema—Carmustine—brain cancer	0.000145	0.000728	CcSEcCtD
Paroxetine—Discomfort—Temozolomide—brain cancer	0.000145	0.000725	CcSEcCtD
Paroxetine—Infection—Carmustine—brain cancer	0.000144	0.000723	CcSEcCtD
Paroxetine—Angiopathy—Etoposide—brain cancer	0.000143	0.000719	CcSEcCtD
Paroxetine—Dry mouth—Temozolomide—brain cancer	0.000143	0.000717	CcSEcCtD
Paroxetine—Immune system disorder—Etoposide—brain cancer	0.000143	0.000715	CcSEcCtD
Paroxetine—Mediastinal disorder—Etoposide—brain cancer	0.000142	0.000714	CcSEcCtD
Paroxetine—Thrombocytopenia—Carmustine—brain cancer	0.000142	0.000712	CcSEcCtD
Paroxetine—Body temperature increased—Hydroxyurea—brain cancer	0.000142	0.000711	CcSEcCtD
Paroxetine—Chills—Etoposide—brain cancer	0.000142	0.000711	CcSEcCtD
Paroxetine—Tachycardia—Carmustine—brain cancer	0.000142	0.00071	CcSEcCtD
Paroxetine—Confusional state—Temozolomide—brain cancer	0.000142	0.000709	CcSEcCtD
Paroxetine—Oedema—Temozolomide—brain cancer	0.00014	0.000703	CcSEcCtD
Paroxetine—Anaphylactic shock—Temozolomide—brain cancer	0.00014	0.000703	CcSEcCtD
Paroxetine—Alopecia—Etoposide—brain cancer	0.00014	0.0007	CcSEcCtD
Paroxetine—Infection—Temozolomide—brain cancer	0.000139	0.000699	CcSEcCtD
Paroxetine—Nausea—Procarbazine—brain cancer	0.000138	0.000691	CcSEcCtD
Paroxetine—Nervous system disorder—Temozolomide—brain cancer	0.000138	0.00069	CcSEcCtD
Paroxetine—Thrombocytopenia—Temozolomide—brain cancer	0.000137	0.000688	CcSEcCtD
Paroxetine—Skin disorder—Temozolomide—brain cancer	0.000136	0.000683	CcSEcCtD
Paroxetine—Hypotension—Carmustine—brain cancer	0.000136	0.00068	CcSEcCtD
Paroxetine—Hyperhidrosis—Temozolomide—brain cancer	0.000136	0.00068	CcSEcCtD
Paroxetine—Dysgeusia—Etoposide—brain cancer	0.000135	0.000675	CcSEcCtD
Paroxetine—ABCB1—central nervous system—brain cancer	0.000134	0.0014	CbGeAlD
Paroxetine—Back pain—Etoposide—brain cancer	0.000133	0.000667	CcSEcCtD
Paroxetine—Hypersensitivity—Hydroxyurea—brain cancer	0.000132	0.000663	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000132	0.000663	CcSEcCtD
Paroxetine—Muscle spasms—Etoposide—brain cancer	0.000132	0.000663	CcSEcCtD
Paroxetine—Insomnia—Carmustine—brain cancer	0.000131	0.000658	CcSEcCtD
Paroxetine—ABCB1—cerebellum—brain cancer	0.000131	0.00137	CbGeAlD
Paroxetine—Paraesthesia—Carmustine—brain cancer	0.00013	0.000653	CcSEcCtD
Paroxetine—Dyspnoea—Carmustine—brain cancer	0.000129	0.000649	CcSEcCtD
Paroxetine—Somnolence—Carmustine—brain cancer	0.000129	0.000647	CcSEcCtD
Paroxetine—Asthenia—Hydroxyurea—brain cancer	0.000129	0.000646	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000128	0.000641	CcSEcCtD
Paroxetine—Ill-defined disorder—Etoposide—brain cancer	0.000128	0.00064	CcSEcCtD
Paroxetine—Anaemia—Etoposide—brain cancer	0.000127	0.000637	CcSEcCtD
Paroxetine—Insomnia—Temozolomide—brain cancer	0.000127	0.000636	CcSEcCtD
Paroxetine—Decreased appetite—Carmustine—brain cancer	0.000126	0.000632	CcSEcCtD
Paroxetine—Paraesthesia—Temozolomide—brain cancer	0.000126	0.000631	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Carmustine—brain cancer	0.000125	0.000628	CcSEcCtD
Paroxetine—Dyspnoea—Temozolomide—brain cancer	0.000125	0.000627	CcSEcCtD
Paroxetine—Somnolence—Temozolomide—brain cancer	0.000125	0.000625	CcSEcCtD
Paroxetine—Pain—Carmustine—brain cancer	0.000124	0.000622	CcSEcCtD
Paroxetine—Constipation—Carmustine—brain cancer	0.000124	0.000622	CcSEcCtD
Paroxetine—Malaise—Etoposide—brain cancer	0.000124	0.000622	CcSEcCtD
Paroxetine—Vertigo—Etoposide—brain cancer	0.000124	0.000619	CcSEcCtD
Paroxetine—Dyspepsia—Temozolomide—brain cancer	0.000124	0.000619	CcSEcCtD
Paroxetine—Leukopenia—Etoposide—brain cancer	0.000123	0.000617	CcSEcCtD
Paroxetine—Diarrhoea—Hydroxyurea—brain cancer	0.000123	0.000616	CcSEcCtD
Paroxetine—Decreased appetite—Temozolomide—brain cancer	0.000122	0.000611	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000121	0.000607	CcSEcCtD
Paroxetine—Fatigue—Temozolomide—brain cancer	0.000121	0.000606	CcSEcCtD
Paroxetine—Loss of consciousness—Etoposide—brain cancer	0.000121	0.000606	CcSEcCtD
Paroxetine—Cough—Etoposide—brain cancer	0.00012	0.000602	CcSEcCtD
Paroxetine—Pain—Temozolomide—brain cancer	0.00012	0.000601	CcSEcCtD
Paroxetine—Constipation—Temozolomide—brain cancer	0.00012	0.000601	CcSEcCtD
Paroxetine—Feeling abnormal—Carmustine—brain cancer	0.00012	0.0006	CcSEcCtD
Paroxetine—Convulsion—Etoposide—brain cancer	0.000119	0.000597	CcSEcCtD
Paroxetine—Hypertension—Etoposide—brain cancer	0.000119	0.000595	CcSEcCtD
Paroxetine—Dizziness—Hydroxyurea—brain cancer	0.000119	0.000595	CcSEcCtD
Paroxetine—Gastrointestinal pain—Carmustine—brain cancer	0.000119	0.000595	CcSEcCtD
Paroxetine—Chest pain—Etoposide—brain cancer	0.000117	0.000587	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000116	0.000583	CcSEcCtD
Paroxetine—Discomfort—Etoposide—brain cancer	0.000116	0.00058	CcSEcCtD
Paroxetine—Feeling abnormal—Temozolomide—brain cancer	0.000116	0.000579	CcSEcCtD
Paroxetine—Abdominal pain—Carmustine—brain cancer	0.000115	0.000575	CcSEcCtD
Paroxetine—Body temperature increased—Carmustine—brain cancer	0.000115	0.000575	CcSEcCtD
Paroxetine—Gastrointestinal pain—Temozolomide—brain cancer	0.000115	0.000575	CcSEcCtD
Paroxetine—Vomiting—Hydroxyurea—brain cancer	0.000114	0.000572	CcSEcCtD
Paroxetine—Rash—Hydroxyurea—brain cancer	0.000113	0.000567	CcSEcCtD
Paroxetine—Confusional state—Etoposide—brain cancer	0.000113	0.000567	CcSEcCtD
Paroxetine—Dermatitis—Hydroxyurea—brain cancer	0.000113	0.000567	CcSEcCtD
Paroxetine—Headache—Hydroxyurea—brain cancer	0.000113	0.000564	CcSEcCtD
Paroxetine—Anaphylactic shock—Etoposide—brain cancer	0.000112	0.000563	CcSEcCtD
Paroxetine—Infection—Etoposide—brain cancer	0.000112	0.000559	CcSEcCtD
Paroxetine—Urticaria—Temozolomide—brain cancer	0.000111	0.000559	CcSEcCtD
Paroxetine—Abdominal pain—Temozolomide—brain cancer	0.000111	0.000556	CcSEcCtD
Paroxetine—Body temperature increased—Temozolomide—brain cancer	0.000111	0.000556	CcSEcCtD
Paroxetine—Thrombocytopenia—Etoposide—brain cancer	0.00011	0.000551	CcSEcCtD
Paroxetine—Tachycardia—Etoposide—brain cancer	0.00011	0.000549	CcSEcCtD
Paroxetine—Skin disorder—Etoposide—brain cancer	0.000109	0.000547	CcSEcCtD
Paroxetine—Hyperhidrosis—Etoposide—brain cancer	0.000109	0.000544	CcSEcCtD
Paroxetine—Hypersensitivity—Carmustine—brain cancer	0.000107	0.000536	CcSEcCtD
Paroxetine—Nausea—Hydroxyurea—brain cancer	0.000107	0.000535	CcSEcCtD
Paroxetine—ABCB1—brain—brain cancer	0.000106	0.00111	CbGeAlD
Paroxetine—Hypotension—Etoposide—brain cancer	0.000105	0.000526	CcSEcCtD
Paroxetine—Asthenia—Carmustine—brain cancer	0.000104	0.000522	CcSEcCtD
Paroxetine—Hypersensitivity—Temozolomide—brain cancer	0.000103	0.000518	CcSEcCtD
Paroxetine—Paraesthesia—Etoposide—brain cancer	0.000101	0.000505	CcSEcCtD
Paroxetine—Asthenia—Temozolomide—brain cancer	0.000101	0.000504	CcSEcCtD
Paroxetine—Dyspnoea—Etoposide—brain cancer	0.0001	0.000502	CcSEcCtD
Paroxetine—Somnolence—Etoposide—brain cancer	9.98e-05	0.0005	CcSEcCtD
Paroxetine—Diarrhoea—Carmustine—brain cancer	9.94e-05	0.000498	CcSEcCtD
Paroxetine—Pruritus—Temozolomide—brain cancer	9.93e-05	0.000497	CcSEcCtD
Paroxetine—Decreased appetite—Etoposide—brain cancer	9.76e-05	0.000489	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Etoposide—brain cancer	9.7e-05	0.000486	CcSEcCtD
Paroxetine—Fatigue—Etoposide—brain cancer	9.68e-05	0.000485	CcSEcCtD
Paroxetine—Dizziness—Carmustine—brain cancer	9.6e-05	0.000481	CcSEcCtD
Paroxetine—Pain—Etoposide—brain cancer	9.6e-05	0.000481	CcSEcCtD
Paroxetine—Constipation—Etoposide—brain cancer	9.6e-05	0.000481	CcSEcCtD
Paroxetine—Diarrhoea—Temozolomide—brain cancer	9.6e-05	0.000481	CcSEcCtD
Paroxetine—Dizziness—Temozolomide—brain cancer	9.28e-05	0.000465	CcSEcCtD
Paroxetine—Feeling abnormal—Etoposide—brain cancer	9.25e-05	0.000464	CcSEcCtD
Paroxetine—Vomiting—Carmustine—brain cancer	9.23e-05	0.000463	CcSEcCtD
Paroxetine—Gastrointestinal pain—Etoposide—brain cancer	9.18e-05	0.00046	CcSEcCtD
Paroxetine—Rash—Carmustine—brain cancer	9.16e-05	0.000459	CcSEcCtD
Paroxetine—Dermatitis—Carmustine—brain cancer	9.15e-05	0.000458	CcSEcCtD
Paroxetine—Headache—Carmustine—brain cancer	9.1e-05	0.000456	CcSEcCtD
Paroxetine—Vomiting—Temozolomide—brain cancer	8.92e-05	0.000447	CcSEcCtD
Paroxetine—Urticaria—Etoposide—brain cancer	8.92e-05	0.000447	CcSEcCtD
Paroxetine—Abdominal pain—Etoposide—brain cancer	8.88e-05	0.000445	CcSEcCtD
Paroxetine—Body temperature increased—Etoposide—brain cancer	8.88e-05	0.000445	CcSEcCtD
Paroxetine—Rash—Temozolomide—brain cancer	8.85e-05	0.000443	CcSEcCtD
Paroxetine—Dermatitis—Temozolomide—brain cancer	8.84e-05	0.000443	CcSEcCtD
Paroxetine—Headache—Temozolomide—brain cancer	8.79e-05	0.00044	CcSEcCtD
Paroxetine—Nausea—Carmustine—brain cancer	8.63e-05	0.000432	CcSEcCtD
Paroxetine—Nausea—Temozolomide—brain cancer	8.34e-05	0.000418	CcSEcCtD
Paroxetine—Hypersensitivity—Etoposide—brain cancer	8.27e-05	0.000415	CcSEcCtD
Paroxetine—Asthenia—Etoposide—brain cancer	8.06e-05	0.000404	CcSEcCtD
Paroxetine—Pruritus—Etoposide—brain cancer	7.95e-05	0.000398	CcSEcCtD
Paroxetine—Diarrhoea—Etoposide—brain cancer	7.68e-05	0.000385	CcSEcCtD
Paroxetine—Dizziness—Etoposide—brain cancer	7.43e-05	0.000372	CcSEcCtD
Paroxetine—Vomiting—Etoposide—brain cancer	7.14e-05	0.000358	CcSEcCtD
Paroxetine—Rash—Etoposide—brain cancer	7.08e-05	0.000355	CcSEcCtD
Paroxetine—Dermatitis—Etoposide—brain cancer	7.07e-05	0.000354	CcSEcCtD
Paroxetine—Headache—Etoposide—brain cancer	7.04e-05	0.000352	CcSEcCtD
Paroxetine—Nausea—Etoposide—brain cancer	6.67e-05	0.000334	CcSEcCtD
Paroxetine—HTR2A—Signaling Pathways—ABR—brain cancer	2.26e-05	0.000454	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ABR—brain cancer	2.25e-05	0.000451	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ABR—brain cancer	2.24e-05	0.00045	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—BSG—brain cancer	2.23e-05	0.000447	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—IDH1—brain cancer	2.23e-05	0.000447	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ABR—brain cancer	2.22e-05	0.000445	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.22e-05	0.000445	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SHH—brain cancer	2.19e-05	0.000439	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—PIK3CG—brain cancer	2.19e-05	0.000439	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—APC—brain cancer	2.19e-05	0.000439	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GLI2—brain cancer	2.18e-05	0.000438	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GLI2—brain cancer	2.17e-05	0.000436	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GLI2—brain cancer	2.16e-05	0.000434	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GLI2—brain cancer	2.14e-05	0.00043	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.14e-05	0.00043	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.14e-05	0.000429	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.13e-05	0.000428	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.12e-05	0.000426	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TRPC6—brain cancer	2.11e-05	0.000424	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SHH—brain cancer	2.1e-05	0.000421	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PTCH1—brain cancer	2.07e-05	0.000416	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SMO—brain cancer	2.07e-05	0.000416	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GLI1—brain cancer	2.05e-05	0.000412	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GLI1—brain cancer	2.04e-05	0.00041	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GLI1—brain cancer	2.03e-05	0.000408	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TRPC6—brain cancer	2.02e-05	0.000406	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GLI1—brain cancer	2.01e-05	0.000404	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—VAV1—brain cancer	2e-05	0.000401	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—EGFR—brain cancer	1.99e-05	0.0004	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	1.99e-05	0.000399	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTCH1—brain cancer	1.99e-05	0.000399	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SMO—brain cancer	1.99e-05	0.000399	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	1.98e-05	0.000398	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	1.96e-05	0.000394	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SUFU—brain cancer	1.95e-05	0.00039	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SUFU—brain cancer	1.93e-05	0.000388	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP2C9—brain cancer	1.93e-05	0.000388	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SUFU—brain cancer	1.93e-05	0.000387	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—IDH1—brain cancer	1.91e-05	0.000384	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SUFU—brain cancer	1.91e-05	0.000383	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.89e-05	0.000379	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—brain cancer	1.89e-05	0.000379	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—BSG—brain cancer	1.88e-05	0.000378	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GFAP—brain cancer	1.88e-05	0.000377	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	1.87e-05	0.000376	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.87e-05	0.000375	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GFAP—brain cancer	1.87e-05	0.000375	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GFAP—brain cancer	1.86e-05	0.000373	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GFAP—brain cancer	1.84e-05	0.00037	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000365	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—VAV1—brain cancer	1.81e-05	0.000364	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—VAV1—brain cancer	1.8e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—VAV1—brain cancer	1.8e-05	0.000361	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	1.79e-05	0.00036	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—VAV1—brain cancer	1.78e-05	0.000358	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HEY1—brain cancer	1.78e-05	0.000357	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HEY1—brain cancer	1.77e-05	0.000355	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HEY1—brain cancer	1.76e-05	0.000354	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ENO2—brain cancer	1.76e-05	0.000353	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HEY1—brain cancer	1.75e-05	0.000351	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—DLL1—brain cancer	1.74e-05	0.00035	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—DLL1—brain cancer	1.74e-05	0.000348	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—DLL1—brain cancer	1.73e-05	0.000347	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—DLL1—brain cancer	1.71e-05	0.000344	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—RELA—brain cancer	1.71e-05	0.000343	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	1.7e-05	0.000341	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—ERBB2—brain cancer	1.7e-05	0.000341	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	1.66e-05	0.000333	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.65e-05	0.00033	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—BSG—brain cancer	1.64e-05	0.00033	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	1.63e-05	0.000327	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—IDH1—brain cancer	1.62e-05	0.000325	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	1.59e-05	0.000319	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VAV1—brain cancer	1.58e-05	0.000317	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—BSG—brain cancer	1.55e-05	0.000311	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2—brain cancer	1.54e-05	0.000309	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—BSG—brain cancer	1.53e-05	0.000308	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.51e-05	0.000304	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VAV1—brain cancer	1.51e-05	0.000304	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ENO2—brain cancer	1.51e-05	0.000304	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CCND1—brain cancer	1.5e-05	0.000301	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CTNNB1—brain cancer	1.49e-05	0.000298	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SHH—brain cancer	1.48e-05	0.000298	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.48e-05	0.000297	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SHH—brain cancer	1.48e-05	0.000296	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SHH—brain cancer	1.47e-05	0.000295	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SHH—brain cancer	1.46e-05	0.000292	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TRPC6—brain cancer	1.43e-05	0.000287	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TRPC6—brain cancer	1.42e-05	0.000286	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TRPC6—brain cancer	1.42e-05	0.000285	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—IDH1—brain cancer	1.41e-05	0.000283	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SMO—brain cancer	1.41e-05	0.000282	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTCH1—brain cancer	1.41e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TRPC6—brain cancer	1.4e-05	0.000282	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SMO—brain cancer	1.4e-05	0.000281	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTCH1—brain cancer	1.4e-05	0.000281	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTCH1—brain cancer	1.39e-05	0.00028	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SMO—brain cancer	1.39e-05	0.00028	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SMO—brain cancer	1.38e-05	0.000277	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTCH1—brain cancer	1.38e-05	0.000277	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HES1—brain cancer	1.36e-05	0.000273	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—IDH1—brain cancer	1.33e-05	0.000267	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.32e-05	0.000265	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—IDH1—brain cancer	1.32e-05	0.000265	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000264	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—VEGFA—brain cancer	1.31e-05	0.000262	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HES1—brain cancer	1.3e-05	0.000261	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	0.00026	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—STAT3—brain cancer	1.29e-05	0.00026	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ENO2—brain cancer	1.28e-05	0.000257	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.27e-05	0.000255	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.26e-05	0.000253	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—brain cancer	1.26e-05	0.000253	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	1.26e-05	0.000252	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SPP1—brain cancer	1.26e-05	0.000252	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.25e-05	0.00025	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.24e-05	0.00025	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	1.24e-05	0.000249	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.000242	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MYC—brain cancer	1.2e-05	0.000241	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—brain cancer	1.2e-05	0.00024	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—EGFR—brain cancer	1.18e-05	0.000236	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.15e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.15e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—brain cancer	1.15e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.14e-05	0.000229	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000228	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.13e-05	0.000227	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.12e-05	0.000226	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.12e-05	0.000224	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ENO2—brain cancer	1.12e-05	0.000224	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.11e-05	0.000224	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.1e-05	0.000222	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IRS2—brain cancer	1.09e-05	0.000218	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.07e-05	0.000216	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.07e-05	0.000215	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VAV1—brain cancer	1.07e-05	0.000214	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VAV1—brain cancer	1.06e-05	0.000213	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.05e-05	0.000211	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ENO2—brain cancer	1.05e-05	0.000211	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ENO2—brain cancer	1.04e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1e-05	0.000201	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—APC—brain cancer	1e-05	0.000201	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—brain cancer	9.88e-06	0.000198	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—APC—brain cancer	9.61e-06	0.000193	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	9.61e-06	0.000193	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HES1—brain cancer	9.22e-06	0.000185	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HES1—brain cancer	9.17e-06	0.000184	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—EGFR—brain cancer	9.15e-06	0.000184	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HES1—brain cancer	9.14e-06	0.000183	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HES1—brain cancer	9.05e-06	0.000182	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—brain cancer	8.93e-06	0.000179	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—brain cancer	8.88e-06	0.000178	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—brain cancer	8.85e-06	0.000178	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	8.78e-06	0.000176	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—brain cancer	8.77e-06	0.000176	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—EGFR—brain cancer	8.76e-06	0.000176	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	8.73e-06	0.000175	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	8.7e-06	0.000175	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	8.62e-06	0.000173	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SPP1—brain cancer	8.52e-06	0.000171	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SPP1—brain cancer	8.47e-06	0.00017	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SPP1—brain cancer	8.45e-06	0.00017	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SPP1—brain cancer	8.37e-06	0.000168	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—brain cancer	8.11e-06	0.000163	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PIK3CG—brain cancer	8.07e-06	0.000162	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—brain cancer	8.06e-06	0.000162	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—brain cancer	8.04e-06	0.000161	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—brain cancer	7.96e-06	0.00016	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RELA—brain cancer	7.84e-06	0.000157	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ERBB2—brain cancer	7.79e-06	0.000156	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IRS2—brain cancer	7.71e-06	0.000155	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IRS2—brain cancer	7.66e-06	0.000154	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IRS2—brain cancer	7.64e-06	0.000153	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IRS2—brain cancer	7.57e-06	0.000152	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RELA—brain cancer	7.51e-06	0.000151	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ERBB2—brain cancer	7.46e-06	0.00015	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—brain cancer	7.06e-06	0.000142	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CG—brain cancer	6.94e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCND1—brain cancer	6.89e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	6.82e-06	0.000137	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APC—brain cancer	6.81e-06	0.000137	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	6.81e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	6.77e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APC—brain cancer	6.77e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—brain cancer	6.76e-06	0.000136	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APC—brain cancer	6.75e-06	0.000135	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	6.75e-06	0.000135	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	6.68e-06	0.000134	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APC—brain cancer	6.68e-06	0.000134	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCND1—brain cancer	6.59e-06	0.000132	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	6.53e-06	0.000131	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—EGFR—brain cancer	6.2e-06	0.000124	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—EGFR—brain cancer	6.17e-06	0.000124	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—EGFR—brain cancer	6.15e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—EGFR—brain cancer	6.09e-06	0.000122	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—brain cancer	6e-06	0.000121	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—brain cancer	5.94e-06	0.000119	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.88e-06	0.000118	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—brain cancer	5.75e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—brain cancer	5.69e-06	0.000114	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MYC—brain cancer	5.52e-06	0.000111	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EGFR—brain cancer	5.4e-06	0.000108	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RELA—brain cancer	5.32e-06	0.000107	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MYC—brain cancer	5.29e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RELA—brain cancer	5.29e-06	0.000106	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ERBB2—brain cancer	5.28e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RELA—brain cancer	5.27e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ERBB2—brain cancer	5.26e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ERBB2—brain cancer	5.24e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RELA—brain cancer	5.22e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ERBB2—brain cancer	5.19e-06	0.000104	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EGFR—brain cancer	5.17e-06	0.000104	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CG—brain cancer	5.12e-06	0.000103	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.82e-06	9.68e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—brain cancer	4.79e-06	9.61e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.78e-06	9.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—brain cancer	4.76e-06	9.56e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—brain cancer	4.75e-06	9.53e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—brain cancer	4.7e-06	9.44e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCND1—brain cancer	4.67e-06	9.37e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCND1—brain cancer	4.64e-06	9.32e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCND1—brain cancer	4.63e-06	9.29e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	4.62e-06	9.28e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	4.6e-06	9.23e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCND1—brain cancer	4.58e-06	9.2e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	4.58e-06	9.2e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	4.54e-06	9.11e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—brain cancer	4.54e-06	9.11e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—brain cancer	4.34e-06	8.72e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—brain cancer	4.07e-06	8.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—brain cancer	4.05e-06	8.13e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—brain cancer	4.04e-06	8.1e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—brain cancer	4.03e-06	8.09e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—brain cancer	4.01e-06	8.05e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—brain cancer	4e-06	8.02e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—brain cancer	4e-06	8.02e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—brain cancer	3.96e-06	7.94e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MYC—brain cancer	3.74e-06	7.52e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MYC—brain cancer	3.72e-06	7.48e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MYC—brain cancer	3.71e-06	7.45e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MYC—brain cancer	3.68e-06	7.38e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EGFR—brain cancer	3.66e-06	7.35e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EGFR—brain cancer	3.64e-06	7.31e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EGFR—brain cancer	3.63e-06	7.29e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EGFR—brain cancer	3.6e-06	7.22e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—brain cancer	3.08e-06	6.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—brain cancer	3.06e-06	6.14e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—brain cancer	3.05e-06	6.12e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—brain cancer	3.02e-06	6.06e-05	CbGpPWpGaD
